Media Summary: Science, Integrity, and the Future of Biologics: A Can you hear us good can okay good this was uh built as a A Conversation: State of Care Delivery in America Speakers Anne Klibanski MD, President & CEO, Mass General Brigham; Laurie ...

2025 Wmif Fireside Chat Focus On Biogen Chris Viehbacher - Detailed Analysis & Overview

Science, Integrity, and the Future of Biologics: A Can you hear us good can okay good this was uh built as a A Conversation: State of Care Delivery in America Speakers Anne Klibanski MD, President & CEO, Mass General Brigham; Laurie ... ... thing that is abundantly clear and that's going to Visit our website: -------- Social Media -------- Follow us on Twitter:

Photo Gallery

2025 WMIF | Fireside Chat | Focus on Biogen | Chris Viehbacher
2025 WMIF | Fireside Chat | Focus on Merck | Eliav Barr MD, CMO, Merck
2023 WMIF | 1:1 Fireside Chat - Meg Tirrell, Chris Viehbacher
2025 WMIF | Fireside Chat | Focus on Amgen | David Reese, MD, EVP & Chief Technology Officer, Amgen
2025 WMIF | Fireside Chat | Focus on Johnson & Johnson | John Reed, MD, PhD
2025 WMIF | Fireside Chat with Dr. Peter Marks, former FDA
2025 WMIF | Fireside Chat | Robert Langer and Rox Anderson MD
Biogen CEO Chris Viehbacher on 2026 drug pipeline outlook, rare disease strategy
2025 WMIF | Fireside Chat: Policy, Congress, FDA
2025 WMIF | Fireside Chat: MGB & Penn Med CEOs
2025 WMIF | Big Ideas Panel
2025 WMIF | Fireside Chat with Jeffrey Balser MD, CEO of Vanderbilt University Medical Center
View Detailed Profile
2025 WMIF | Fireside Chat | Focus on Biogen | Chris Viehbacher

2025 WMIF | Fireside Chat | Focus on Biogen | Chris Viehbacher

Fireside Chat

2025 WMIF | Fireside Chat | Focus on Merck | Eliav Barr MD, CMO, Merck

2025 WMIF | Fireside Chat | Focus on Merck | Eliav Barr MD, CMO, Merck

Fireside Chat

2023 WMIF | 1:1 Fireside Chat - Meg Tirrell, Chris Viehbacher

2023 WMIF | 1:1 Fireside Chat - Meg Tirrell, Chris Viehbacher

1:1

2025 WMIF | Fireside Chat | Focus on Amgen | David Reese, MD, EVP & Chief Technology Officer, Amgen

2025 WMIF | Fireside Chat | Focus on Amgen | David Reese, MD, EVP & Chief Technology Officer, Amgen

Fireside Chat

2025 WMIF | Fireside Chat | Focus on Johnson & Johnson | John Reed, MD, PhD

2025 WMIF | Fireside Chat | Focus on Johnson & Johnson | John Reed, MD, PhD

Fireside Chat

2025 WMIF | Fireside Chat with Dr. Peter Marks, former FDA

2025 WMIF | Fireside Chat with Dr. Peter Marks, former FDA

Science, Integrity, and the Future of Biologics: A

2025 WMIF | Fireside Chat | Robert Langer and Rox Anderson MD

2025 WMIF | Fireside Chat | Robert Langer and Rox Anderson MD

Can you hear us good can okay good this was uh built as a

Biogen CEO Chris Viehbacher on 2026 drug pipeline outlook, rare disease strategy

Biogen CEO Chris Viehbacher on 2026 drug pipeline outlook, rare disease strategy

Biogen

2025 WMIF | Fireside Chat: Policy, Congress, FDA

2025 WMIF | Fireside Chat: Policy, Congress, FDA

Fireside

2025 WMIF | Fireside Chat: MGB & Penn Med CEOs

2025 WMIF | Fireside Chat: MGB & Penn Med CEOs

A Conversation: State of Care Delivery in America Speakers Anne Klibanski MD, President & CEO, Mass General Brigham; Laurie ...

2025 WMIF | Big Ideas Panel

2025 WMIF | Big Ideas Panel

All right thank you

2025 WMIF | Fireside Chat with Jeffrey Balser MD, CEO of Vanderbilt University Medical Center

2025 WMIF | Fireside Chat with Jeffrey Balser MD, CEO of Vanderbilt University Medical Center

Fireside Chat

2025 WMIF | First Look | Richard Blumberg MD

2025 WMIF | First Look | Richard Blumberg MD

... thing that is abundantly clear and that's going to

FIRESIDE CHAT | Unleashing the future of Life Sciences I HCS 2025

FIRESIDE CHAT | Unleashing the future of Life Sciences I HCS 2025

Visit our website: https://www.politico.eu/ -------- Social Media -------- Follow us on Twitter: https://twitter.com/POLITICOEurope ...